蛋白質治療市場：按蛋白質功能、產品類型分類 - 2023-2030 年全球預測

全球蛋白質治療市場預計到 2023 年將大幅成長 786.6 億美元，複合年成長率為 7.88%，到 2030 年將達到驚人的 1,339.8 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球蛋白質治療市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 蛋白質療法的全球市場規模與預測為何？

2.在預測期內，COVID-19對全球蛋白質治療市場的阻礙因素與影響為何？

3. 在預測期內，全球蛋白質治療市場需要投資哪些產品/細分市場/應用/領域？

4. 全球蛋白質治療市場的競爭策略是什麼？

5. 全球蛋白質治療市場的技術趨勢和法律規範是什麼？

6. 全球蛋白質治療市場主要供應商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球蛋白質治療市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 新興市場醫療保健支出不斷增加
    • 政府配合措施改善醫療服務
    • 老年人口增加和慢性病盛行率上升
  • 抑制因素
    • 蛋白質療法的局限性，包括生產成本高和組織滲透效率低的大蛋白質
    • 由於腸道變性，對口服藥物可用性的擔憂
  • 機會
    • 雙特異性單株抗體的潛力
    • 新興國家未滿足的醫療需求
  • 任務
    • 製造加工成本高
    • 與生物相似藥的競爭
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 依蛋白質功能分類的蛋白質治療藥物市場

• 酶和調節
• 蛋白質診斷
• 疫苗

第7章 蛋白質治療市場：依產品類型

• 凝血因子
• 促紅血球生成素
• 卵泡刺激素
• G-CSF
• 胰島素
• 干擾素
• 單株抗體

第8章 美洲蛋白質治療市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太蛋白質治療市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲蛋白質治療市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可證和定價

The Global Protein Therapeutics Market is forecasted to grow significantly, with a projected USD 78.66 billion in 2023 at a CAGR of 7.88% and expected to reach a staggering USD 133.98 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Protein Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Protein Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Protein Function, market is studied across Enzymatic & Regulatory, Protein Diagnostics, and Vaccines. The Protein Diagnostics is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies. The Monoclonal Antibodies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Protein Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Protein Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Protein Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Protein Therapeutics Market?

6. What is the market share of the leading vendors in the Global Protein Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Protein Therapeutics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Protein Therapeutics Market, by Protein Function, 2022 vs 2030
• 4.3. Protein Therapeutics Market, by Product Type, 2022 vs 2030
• 4.4. Protein Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing healthcare expenditure in the emerging markets
    • 5.1.1.2. Government initiatives to improve the healthcare services
    • 5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
    • 5.1.2.2. Availability concerns as oral drugs due to denaturation in the gut
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential for bispecific monoclonal antibodies
    • 5.1.3.2. Unmet medical needs in developing countries
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of production and treatment
    • 5.1.4.2. Competition from biosimilars
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Protein Therapeutics Market, by Protein Function

• 6.1. Introduction
• 6.2. Enzymatic & Regulatory
• 6.3. Protein Diagnostics
• 6.4. Vaccines

7. Protein Therapeutics Market, by Product Type

• 7.1. Introduction
• 7.2. Blood Clotting Factor
• 7.3. Erythropoietin
• 7.4. Follicle Stimulating Hormone
• 7.5. G-CSF
• 7.6. Insulin
• 7.7. Interferons
• 7.8. Monoclonal Antibodies

8. Americas Protein Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Protein Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Protein Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. PROTEIN THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. PROTEIN THERAPEUTICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2022 VS 2030 (%)
• FIGURE 5. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
• FIGURE 6. PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. PROTEIN THERAPEUTICS MARKET DYNAMICS
• FIGURE 8. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PROTEIN THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 5. PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC & REGULATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 9. PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 24. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 36. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 38. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 73. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 81. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 83. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 103. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 104. PROTEIN THERAPEUTICS MARKET LICENSE & PRICING